SOP Guide for Pharma

Creams: SOP for Conducting FTIR Analysis of Cream Ingredients – V 2.0

Creams: SOP for Conducting FTIR Analysis of Cream Ingredients – V 2.0

Standard Operating Procedure for Conducting FTIR Analysis of Cream Ingredients

Department Creams
SOP No. SOP/CRM/136/2025
Supersedes SOP/CRM/136/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for conducting Fourier Transform Infrared (FTIR) analysis of cream ingredients. FTIR analysis is used to identify the chemical composition of active ingredients and excipients in cream formulations. This test ensures the quality and integrity of the ingredients, confirming their authenticity and purity.

2. Scope

This SOP applies to all cream formulations produced at the facility. It covers the procedure for conducting FTIR analysis on raw materials, active ingredients, and finished cream products to verify their chemical composition and quality.

3. Responsibilities

  • Production Team: Responsible for providing representative samples of ingredients and finished cream products for FTIR analysis.
  • Quality Control (QC) Team: Responsible for performing FTIR analysis using the FTIR spectrometer and ensuring the test results meet the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing the FTIR test results to ensure compliance with internal and regulatory standards, and approving the use of ingredients and finished products for
further processing or release.

4. Accountability

The QC Manager is accountable for ensuring that FTIR analysis is conducted in accordance with this SOP. The Production Supervisor is responsible for providing accurate and representative samples for testing. The QA Manager ensures that the results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the FTIR spectrometer is calibrated according to the manufacturer’s instructions to ensure accurate readings.
  2. Ensure that the necessary sample preparation tools and solvents (e.g., potassium bromide, ethanol) are available and ready for use.
  3. Review the batch record to determine the specific ingredients and cream samples to be tested and to confirm the test specifications.

5.2 Sample Collection

  1. Collect representative samples of the cream ingredients and finished product formulations. The samples should be homogenous and free from contamination.
  2. Label each sample with the batch number, sample ID, sampling date, and the ingredients used in the formulation to ensure traceability during testing.
  3. Ensure that the samples are collected from properly prepared and finalized formulations, ready for testing.

5.3 FTIR Analysis Procedure

  1. Prepare the sample for FTIR analysis by placing a small amount of the sample (e.g., 1-2 mg) onto a potassium bromide (KBr) pellet or directly on the FTIR sample plate.
  2. Place the prepared sample into the FTIR spectrometer. Ensure that the sample is positioned correctly to obtain a clean reading.
  3. Run the FTIR scan within the designated range (typically 4000–400 cm⁻¹) to obtain the infrared absorption spectrum of the sample.
  4. Perform the scan according to the instrument’s specifications. Ensure that each sample is scanned at least three times for consistency.
  5. Record the FTIR spectrum generated by the instrument for analysis. Compare the observed peaks with known reference spectra for each ingredient to confirm the chemical composition of the sample.

5.4 Interpretation of Results

  1. Compare the FTIR spectrum of the sample with reference spectra from recognized sources (e.g., ingredient suppliers, published libraries) to confirm the identity and purity of the active ingredients and excipients.
  2. Verify that the spectrum matches the expected profile for the ingredient. If the spectrum differs significantly, mark the test as “Fail” and investigate the cause of the discrepancy.
  3. If the FTIR spectrum confirms the expected identity, mark the test as “Pass” in the FTIR Test Log (Annexure-1) and proceed with the next stage of production or release.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, FTIR spectrum, and any discrepancies or deviations observed, in the FTIR Test Log (Annexure-1).
  2. If the FTIR analysis fails, initiate corrective actions, such as reviewing the raw material batch, checking supplier certificates of analysis, or re-testing the sample with different preparation methods.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all FTIR testing records are complete, accurate, and securely stored. This includes the FTIR Test Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • FTIR: Fourier Transform Infrared

7. Documents

  1. Annexure-1: FTIR Test Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for FTIR Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: FTIR Test Log

Batch Number Sample ID Test Date FTIR Spectrum Operator
12345 S-001 21/01/2026 Pass (Spectra matched with reference) John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Discrepancy in FTIR spectrum Re-tested with new sample preparation Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
Exit mobile version